Transcript Document

Health Technologies Adoption Programme
Stephen Hodges – Technology Implementation Manager
Where HTAP came from
• NTAC 2007
• Set up by Department of Health to identify
barriers to technology adoption
• Based in Manchester, worked across UK
• Technologies identified by calls to the NHS and
industry, over time increasing joint work with
NICE
• How2Why2 Guides
• Commercial support to industry
How NTAC arrived at NICE
• Innovation, Health and Wealth (2011)
Accelerating adoption and diffusion in the NHS
o Sunset Review
• Recommended transfer to NICE
• Memorandum of understanding with NHS England
Skills & experience within the team
• All team clinically qualified
• Primary, acute, mental health and social care
experience
• Commissioners, providers, management
(community and acute), strategic service
planning, service redesign
• Health visiting, child protection, research, clinical
risk and complaints, patient involvement
HTAP Objectives
• Assess the factors that will promote access to
and increase the uptake of NICE guidance
(MTEP/DAP/TA)
• Establish an agreed approach for NICE to
develop effective partnerships with AHSNs
• To support the expansion of the medical
technologies industry in the UK by providing
advice to suppliers
Device
Test
Manufacturers
notify topics to
NICE
Medical Technologies Advisory Committee
(MTAC)
Medical
Technologies
Evaluation
Programme
(MTEP)
Diagnostics
Assessment
Programme
(DAP)
Technology
Appraisals
(TA)
HTAP
MTAC
Med Tech
Company
Selection process
DAP
MTEP
Adoption Support
• Retrospective
• Prospective
Guidance
Publication
Advisory
Consultation
meeting
Clinical
associates
How does HTAP work?
Resources aligned to NICE Guidance
• Technology in use in the NHS
- demonstrator projects
• Technology in use in the NHS, less common &
more complex
- adoption projects
Example…
Availability
Although most operating theatres and intensive care units have access
to fibre optic endoscopes, common situations which might reduce this
availability include:
• The requirement to sterilise multiple use endoscopes after every use
and every 72 hours when not used. This is commonly carried out in
a central endoscope processing unit and will remove the endoscope
from use for a number of hours.
• Use of an endoscope out of routine working hours, such as during
the night or when the processing unit is closed, may result in the
equipment being removed from service for up to 2 days.
• The need for multiple use endoscopes to be regularly maintained
and on occasion repaired.
Practical Examples
Workforce considerations
Staffing
Whilst visiting NHS sites to discuss the use of Ambu aScope2, HTAP found that the impact
of implementation upon staffing is minimal. The Ambu aScope2 does not introduce any new
clinical techniques, move the setting of care or impact upon current role boundaries.
Training
Training staff to use the Ambu aScope2 is initially undertaken by the manufacturer. Ambu
have a Training Specialist in Airway Visualisation who offers bespoke training to NHS sites.
Training may then be disseminated within a department with an anaesthetist or senior ODP
usually taking the lead.
Benefits reported by Trusts
• Improved safety – having access to an
endoscope immediately at the point of need.
• Reduced likelihood of re-scheduling of surgery
• Ease of use in the hands of a skilled operator –
does not require a new skill set to be learned.
• Easy to transport to the point of use.
• Endoscopes are packaged sterile and are single
patient use so do not need to be disinfected prior
to or following use.
• No need for repairs or maintenance – the Ambu
aScope2 is disposable. If it gets damaged during
a procedure, this will have no major clinical or
financial consequences in terms of endoscope
unavailability or repair costs.
Common adoption hurdles
•
•
•
•
•
•
•
Financing – capital and revenue
Pathway re-design
Clinical utility
Decommissioning
Role expansion
Education
Realising efficiencies
So what are the
critical adoption success factors?
• How to plan and support the process of adoption
– Local decision making processes
– Clinical and Managerial Champions
– Local strategies/priorities
• How the pathway changes
– Current care pathway & service delivery models
– Avoidance of hospital attendance
– Offering faster access to a diagnosis
…so what are the
critical adoption success factors?
• Understand quality
– Training, competence, safe environment
• Business case
– Local business case process
– Capital & revenue, efficiencies and outcomes
• Data
– Baseline & change
Commercial offering…
• SAP
• Support the medical technologies industry by
providing bespoke adoption advice to
manufacturers and suppliers
• HTAP reference panel
• Adoption clinics
Contact details
Jae Long
[email protected]
nice.org.uk